DocSym
β
Searchsearch
Search
(C76.1) Malignant neoplasm of other and ill-defined sites: thorax
More details coming soon
526 166 in individuals diagnosis malignant neoplasm of other and ill-defined sites: thorax confirmed
230 464 deaths with diagnosis malignant neoplasm of other and ill-defined sites: thorax
44% mortality rate associated with the disease malignant neoplasm of other and ill-defined sites: thorax
Diagnosis malignant neoplasm of other and ill-defined sites: thorax is diagnosed Women are 11.09% more likely than Men
233 915
Men receive the diagnosis malignant neoplasm of other and ill-defined sites: thorax
110 882 (47.4 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
292 251
Women receive the diagnosis malignant neoplasm of other and ill-defined sites: thorax
119 582 (40.9 %)Died from this diagnosis.
Risk Group for the Disease malignant neoplasm of other and ill-defined sites: thorax - Men and Women aged 60-64
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features malignant neoplasm of other and ill-defined sites: thorax
Absence or low individual and public risk
Malignant neoplasm of other and ill-defined sites: thorax - what does this mean
Malignant neoplasm of other and ill-defined sites in the thorax is a type of cancer that arises from cells in the thoracic region, including the lungs, chest wall, pleura, diaphragm, mediastinum, and pericardium. it can be caused by genetic mutations, environmental factors, or a combination of both.
What happens during the disease - malignant neoplasm of other and ill-defined sites: thorax
The pathogenesis of malignant neoplasm of other and ill-defined sites in the thorax is not well understood, but it is thought to be caused by genetic mutations that lead to uncontrolled cell growth and proliferation. this abnormal cell growth can spread to other parts of the body, leading to the formation of a tumor. in some cases, environmental factors may also play a role in the development of the disease.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Review of medical history and physical examination
- Imaging studies such as X-rays, CT scans, MRI scans, PET scans, or ultrasound
- Biopsy of the affected area
- Blood tests to measure tumor markers
- Endoscopic procedures
- Thoracentesis (fluid removal from the chest)
- Bronchoscopy (examination of the airways)
- Thoracoscopy (examination of the chest cavity)
- Needle biopsy
- Thoracotomy (surgical incision of the chest wall)
Treatment and Medical Assistance
Main goal of the treatment: To reduce the size of the malignant neoplasm and improve the patient's quality of life.
- Chemotherapy
- Radiation therapy
- Surgery
- Targeted therapy
- Immunotherapy
- Clinical trials
17 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Malignant neoplasm of other and ill-defined sites: thorax - Prevention
The best way to prevent malignant neoplasm of other and ill-defined sites in the thorax is to practice a healthy lifestyle. this includes eating a balanced diet, exercising regularly, avoiding smoking, limiting alcohol consumption, and getting regular screenings for cancer. additionally, it is important to be aware of any changes in your body and to report them to your doctor immediately.